Eli Lilly announced Monday that it is acquiring Kelonia Therapeutics, a developer of gene therapies with a particular focus on cancer treatment, in a deal valued at up to $7 billion in cash.
โก
Key Insights
10 AI-generated analytical points ยท Not copied from source
J
Joanna Glasner
๐ก
Original Source
Crunchbase News
https://news.crunchbase.com/ma/lilly-acquiring-kelonia-cancer-treatment-biotech-startup/Deep Analysis
Original editorial research ยท AiFeed24 Intelligence Desk
โฆ AiFeed24 Original
Multi-Source Intelligence
AI-synthesized from 5-10 independent sources
Fact Check
Multi-source verificationFound this useful? Share it!
Read the Full Story
Continue reading on Crunchbase News
Related Stories

๐Startups
IBM charts AI operating model to move enterprises beyond experimentation
about 3 hours ago

๐Startups
Opaque buys post-quantum cryptographic AI tech from Abu Dhabiโs TII
about 17 hours ago

๐Startups
AI agent startup Sierra valued at $15B in new $950M funding round
about 6 hours ago

๐Startups
Anthropic and OpenAI establish joint ventures on Wall Street to accelerate enterprise AI adoption
about 6 hours ago
